AT519109T - Preeclampsia-DIAGNOSIS - Google Patents

Preeclampsia-DIAGNOSIS

Info

Publication number
AT519109T
AT519109T AT05857213T AT05857213T AT519109T AT 519109 T AT519109 T AT 519109T AT 05857213 T AT05857213 T AT 05857213T AT 05857213 T AT05857213 T AT 05857213T AT 519109 T AT519109 T AT 519109T
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
Prior art date
Application number
AT05857213T
Other languages
German (de)
Inventor
Irina Buhimschi
Catalin Buhimschi
Errol Norwitz
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US63794804P priority Critical
Application filed by Univ Yale filed Critical Univ Yale
Priority to PCT/US2005/047010 priority patent/WO2006069373A2/en
Publication of AT519109T publication Critical patent/AT519109T/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/321Arterial hypertension
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
AT05857213T 2004-12-21 2005-12-21 Preeclampsia-DIAGNOSIS AT519109T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US63794804P true 2004-12-21 2004-12-21
PCT/US2005/047010 WO2006069373A2 (en) 2004-12-21 2005-12-21 Diagnosis of preeclampsia

Publications (1)

Publication Number Publication Date
AT519109T true AT519109T (en) 2011-08-15

Family

ID=36602368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857213T AT519109T (en) 2004-12-21 2005-12-21 Preeclampsia-DIAGNOSIS

Country Status (7)

Country Link
US (3) US7727733B2 (en)
EP (2) EP1839056B1 (en)
JP (1) JP5009811B2 (en)
CN (1) CN101163970A (en)
AT (1) AT519109T (en)
ES (2) ES2475975T3 (en)
WO (1) WO2006069373A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435419B2 (en) 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
US7335362B2 (en) 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
DK2308507T3 (en) * 2002-07-19 2015-04-20 Beth Israel Hospital Methods for the treatment of preeclampsia
EP1773349A4 (en) * 2004-05-04 2009-07-29 Childrens Medical Center Methods and compositions for treatment of preeclampsia
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
JP5270161B2 (en) * 2004-09-24 2013-08-21 ベス イスラエル デアコネス メディカル センター How to diagnose and treat pregnancy complications
US7740849B2 (en) 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
KR20070092737A (en) * 2004-12-15 2007-09-13 베스 이스라엘 데코니스 메디칼 센터 Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
ES2475975T3 (en) * 2004-12-21 2014-07-11 Yale University Preeclampsia diagnosis
JP2008537776A (en) * 2005-03-24 2008-09-25 ベス イスラエル デアコネス メディカル センター Method of diagnosing fetal trisomy 13 or risk of fetal trisomy 13 during pregnancy
WO2007051069A2 (en) * 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia
US20070111326A1 (en) * 2005-11-14 2007-05-17 Abbott Laboratories Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
EP1903339B1 (en) * 2006-09-20 2010-08-04 Roche Diagnostics GmbH Natriuretic peptides and placental-growth factor/soluble VEGF-receptor discriminate cardiac dysfunction related to heart disease from a placenta-associated cardiac dysfunction in pregnant woman
JP2010512781A (en) * 2006-12-20 2010-04-30 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Variants of VEGFR and its use in the diagnosis and treatment of pregnancy related medical conditions
CN101259119B (en) * 2007-03-08 2010-05-19 上海市计划生育科学研究所 Application of serine protease inhibitor and its derivative in fertility regulation
CN101918834B (en) * 2008-01-07 2014-05-28 奥索临床诊断有限公司 Calibrator/control for simultaneous assay of proteins capable of complexing with one another
RU2010133157A (en) 2008-01-07 2012-02-20 Орто-Клиникал Дайэгностикс, Инк. (Us) Definition of the sflt-1 complex: angiogenic factor
US8647832B2 (en) * 2008-01-25 2014-02-11 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease
CN107677829A (en) 2008-10-31 2018-02-09 耶鲁大学 Preeclampsia detects and the method and composition for the treatment of
CN102224420B (en) * 2008-11-24 2014-09-17 科尔泰拉公司 Prediction and prevention of preeclampsia
US20120101021A1 (en) 2009-02-06 2012-04-26 Surendra Sharma Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
CN101643785B (en) * 2009-06-18 2011-12-21 中国人民解放军第二军医大学 hsa-mir-210 kit for detecting pregnancy-hypertension syndrome and detecting method thereof
AU2011240039B2 (en) * 2010-04-13 2017-01-19 Mycartis Nv Biomarkers for hypertensive disorders of pregnancy
US20110251094A1 (en) 2010-04-13 2011-10-13 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
AU2011252954B2 (en) 2010-05-14 2015-04-16 Beth Israel Deaconess Medical Center Extracorporeal devices and methods of treating complications of pregnancy
CA2886489A1 (en) 2011-10-14 2013-04-18 Aarhus Universitet Diagnostic and prognostic use of prombp-complexes
EP2836832A4 (en) * 2012-04-13 2015-10-14 Univ Wayne State Early trimester screening for early- and late-onset preeclampsia
US20150099655A1 (en) * 2012-05-08 2015-04-09 The Board Of Trustees Of The Leland Stanford Junior University Methods and Compositions for Providing a Preeclampsia Assessment
JP5937756B2 (en) 2012-06-27 2016-06-22 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Means and methods for applying sFlt-1 / PlGF ratio or endoglin / PlGF ratio to rule out the onset of preeclampsia within a specified period
KR101921787B1 (en) * 2012-09-04 2018-11-23 플루리스템 리미티드 Methods for prevention and treatment of preeclampsia
RU2519083C1 (en) * 2012-10-29 2014-06-10 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ ОММ" Минздравсоцразвития России) Method for prediction of hypertension complications of pregnancy in patients suffering from gestational diabetes mellitus
GB201303649D0 (en) 2013-03-01 2013-04-17 Univ Aston Hydrogen sulphide compounds
CN103207274B (en) * 2013-04-28 2015-02-25 成都中医药大学 Screening kit for seventh chromosome abnormality diseases of fetus
CN105917233B (en) * 2014-01-24 2018-07-03 豪夫迈·罗氏有限公司 Postpartum HELLP syndrome, postpartum eclampsia or the prediction of postpartum eclampsia early period
FR3017955B1 (en) * 2014-02-27 2018-04-06 Assistance Publique - Hopitaux De Paris BIOMARKERS DIAGNOSTICS OF PERIPARTUM CARDIOMYOPATHY
CA2945058A1 (en) 2014-04-10 2015-10-15 Yale University Methods and compositions for detecting misfolded proteins
WO2016019176A1 (en) * 2014-07-30 2016-02-04 Matthew Cooper Methods and compositions for diagnosing, prognosing, and confirming preeclampsia
CN107636466B (en) * 2015-02-18 2020-07-21 阿斯顿大学 Diagnostic assay and treatment of preeclampsia
CA2998275A1 (en) * 2015-09-11 2017-03-16 Universidad De Los Andes In vitro method for identifying a pregnancy related disease
CN107884570A (en) * 2016-09-29 2018-04-06 韦彦余 A kind of pregnant woman's pre-eclampsia detection kit

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5998216A (en) * 1996-10-01 1999-12-07 Beth Israel Deaconess Medical Center Stabilizing formulation for preserving the integrity of proteins present in a body fluid sampled ex-vivo for evaluation as a specimen
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
CA2430889A1 (en) * 2002-06-19 2003-12-19 Bayer Corporation Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
US6891006B2 (en) 2002-06-21 2005-05-10 Exxonmobil Chemical Patents Inc. Yttrium-based ethylene polymerization catalysts with bulky amidinate ancillary ligands
DK2308507T3 (en) * 2002-07-19 2015-04-20 Beth Israel Hospital Methods for the treatment of preeclampsia
DK1388734T3 (en) * 2002-08-01 2004-05-03 Mtm Lab Ag Method for solution-based diagnosis
CA2509063C (en) * 2002-11-16 2010-11-02 Dade Behring Marburg Gmbh Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases
KR20070092737A (en) * 2004-12-15 2007-09-13 베스 이스라엘 데코니스 메디칼 센터 Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
ES2475975T3 (en) * 2004-12-21 2014-07-11 Yale University Preeclampsia diagnosis
WO2007051069A2 (en) 2005-10-27 2007-05-03 Yale University Urinary proteomic biomarker patterns in preeclampsia

Also Published As

Publication number Publication date
ES2475975T3 (en) 2014-07-11
US20060183175A1 (en) 2006-08-17
JP2008524635A (en) 2008-07-10
EP2434283B1 (en) 2014-03-26
EP1839056A4 (en) 2008-05-21
JP5009811B2 (en) 2012-08-22
EP1839056A2 (en) 2007-10-03
CN101163970A (en) 2008-04-16
US7727733B2 (en) 2010-06-01
US8871448B2 (en) 2014-10-28
EP1839056B1 (en) 2011-08-03
US7935496B2 (en) 2011-05-03
WO2006069373A8 (en) 2006-09-14
US20100227342A1 (en) 2010-09-09
EP2434283A3 (en) 2012-07-11
US20120040371A1 (en) 2012-02-16
ES2371084T3 (en) 2011-12-27
EP2434283A2 (en) 2012-03-28
WO2006069373A2 (en) 2006-06-29
WO2006069373A3 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
LU92768I2 (en) secukinumab
DK1833840T3 (en) Micromirs
DK1587343T3 (en) Höreapparat
DK1737504T3 (en) Silikonehudpåføringsgel
DK1809382T3 (en) Tokomponenttandblegningssammensætninger
DK1712547T3 (en) bicycloester
FR2872260B1 (en) aerateur
DK1720859T3 (en) Chemokinreceptorantagonister
DK1725553T3 (en) Tetrahydropyridoindolderivater
DK1719228T3 (en) Kabelindföringsindretning
AT415976T (en) Brombeerextrakt
AT539708T (en) Wirbelfazettengelenkprothese
DE602005020259D1 (en) Polyaxialpedikelschraubenanordung
DE602005015457D1 (en) ungselements
AT447853T (en) Enyzmgranulat
DE602005022822D1 (en) pitze
AT415112T (en) Abschminkapplikator
AT360450T (en) Sicherheitsdauerverweilnadel
DE502005005035D1 (en) Wischblatt
AT401806T (en) Einlegesohle
DE602005016543D1 (en) unterkiefervorschiebeorthese
DE602005019073D1 (en) Zenteseinstrument
AT524255T (en) Feinguss
AT538176T (en) Polymilchsäureharzzusammensetzung
DE502005005628D1 (en) Wischblatt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties